Chemokine IP-10: an adjunct marker for latent tuberculosis infection in children

Jennifer Lighter1, M Rigaud, M Huie

  • 1Saul Krugman Division of Pediatric Infectious Diseases and Immunology, New York University School of Medicine, New York, New York 10016, USA. lightj03@med.nyu.edu

Insights

Chemokine inducible protein 10 (IP-10) shows promise for diagnosing Mycobacterium tuberculosis infection in children. Combining IP-10 with interferon-gamma (IFN-γ) may improve diagnostic accuracy, particularly in young children.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Diagnostics

Background:

  • Chemokine inducible protein 10 (IP-10) has been implicated in Mycobacterium tuberculosis (M. tuberculosis) infection.
  • Elevated IP-10 levels are observed in plasma and at infection sites in individuals with M. tuberculosis.

Purpose of the Study:

  • To assess IP-10 as a diagnostic marker for M. tuberculosis infection in children.
  • To evaluate IP-10 in a low tuberculosis (TB) prevalence region.

Main Methods:

  • Whole blood from 127 children was stimulated with M. tuberculosis-specific antigens to measure IP-10 levels.
  • IP-10 results were analyzed against TB exposure risk, tuberculin skin test, and interferon-gamma release assay (IGRA).

Main Results:

  • IP-10 reactivity correlated with M. tuberculosis exposure risk and IGRA results.
  • IP-10 responses were not age-dependent and identified more positive cases in children under 5 years old compared to interferon-gamma (IFN-γ).
  • IGRA demonstrated higher sensitivity than IP-10 in detecting active M. tuberculosis disease.

Conclusions:

  • IP-10, when used with IFN-γ, may enhance the diagnostic performance of IGRAs for M. tuberculosis infection.
  • This combination is particularly beneficial for diagnosing TB in young children.
Abstract

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...